Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Multiphasic Screening”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1977

Multiphasic screening. Case-finding tool in a Teaching Hospital Medical Clinic.

Multiphasic screening as a case-finding tool was evaluated in a randomized, controlled study. For each of 112 physicians, a patient was assigned to one of three groups: multiphasic screening group (SG), chart abstract group (AG), or chart review group (RG). Medical problem lists constructed before and after receiving additional information were compared. Physicians for 36 SG patients identified considerably more new medical problems, both total (77) and ones they considered important (25), than 40 AG physicians (14 and 8) and 36 RG physicians (4 and 0). One year later, 38 of the 95 newly identified problems had been acted on, 31 in the SG. Medical care was affected in nine patients: six in SG, two in AG, and one in RG. Multiphasic screening may help physicians identify new medical problems in clinic patients.

Adult↗
PubMed1975

[Methods and specificity of internal medicine specialties in multiphasic screening].

Issuing from the classical definitions for the diagnostic sensitivity and specifity of examination methods in multiphasic screenings is deduced that out of the whole methodical spectre of internal specialities only limited parts are to be applied in multiphasic screenings. At the instance of a multiple multiphasic screenings (model study Sternberg '70) ways to the establishment of reduced optimal parameter combinations are demonstrated. With multivariate statistical methods (facotor analysis, discriminative methods) we succeeded in finding parameter combinations for special groups of diagnosis (liver diseases, hypertension and obesity), by means which these groups in multiphasic screenings are clearly to be differentiated from the healthy symptom-free residual population.

Cardiovascular Diseases↗
PubMed1975

Two-step electrocardiogram for chest pain reported on multiphasic screening.

Among 264 consecutive persons (142 men, 122 women) greater than or equal to 35 years of age presenting for multiphasic screening examination, 85 (54 men, 31 women) reported chest pain. In most, the pain was not typical of coronary artery disease. The two-step exercise electrocardiogram (ECG) was positive (greater than or equal to 0.5-mm ischemic ST depression) in 21% of the patients who reported pain and in 19.5% of 66 randomly selected, similarly examined controls without chest pain (36 men, 30 women) (difference not significant). Females with positive ECGs (5-mm or 1-mm depression) predominated over males greater than or equal to 5:1 in the chest pain group and greater than 3:1 in controls. This study indicates that the routine two-step exercise ECG is not helpful in detecting ischemic heart disease in persons reporting chest pain during their multiphasic screening examination.

Adult↗
PubMed1977

A controlled trial of multiphasic screening in middle-age: results of the South-East London Screening Study. The South-East London Screening Study Group.

The results of a controlled trial of multiphasic screening in general practice are presented. In 1967, 7,229 individuals aged between 40 and 64 years were randomly allocated into either a Screening or Control group. The Screening group were invited to attend two screening sessions held about two years apart, while the Control group continued to receive conventional medical care. Both groups were then invited to undergo a health survey in 1972-73 which revealed no significant differences in morbidity between the two groups. Careful follow-up permitted detailed Screening-Control comparisons of various outcome measures--consultation and hospital admission rates, certified sickness absence from work, and mortality. Nine years after the initial screening, no significant differences were found between the two groups in any of the outcome measures. It is estimated that a similar screening programme for the entire middle-aged UK population would cost 142 pounds million at 1976 prices.

Aged↗
PubMed1978

Patient education and multiphasic screening: it can change behavior.

Two hundred ninety-two residents of Sonoma County, California, underwent multiphasic screeening and two sessions of group patient education aimed at reducing risk factors for cardiovascular disease, cancer, and automobile accidents. Approximately one year later all the participants were retested. A significant reduction was noted in systolic blood pressure in men and women, ages 50 to 70, cholesterol in men over age 40, and reported alcohol consumption in men. A significant increase was noted in the reported frequency of monthly breast self-examination in women, and in the amount of exercise and percentage of time seat belts were used in both sexes. No change was noted in reported amount of cigarette smoking, weight, fasting blood glucose, and triglycerides. The combined use of health hazard appraisal, multiphasic screening, and patient education can lead to a reduction in cardiac and other risk factors in well-motivated groups.

Adult↗
PubMed1976

An evaluation of multiphasic screening on admission to hospital. Precis of a report to the National Health and Medical Research Council.

A controlled study of admission multiphasic screening (AMS) at a large general hospital showed that AMS had no significant effect on a variety of indices of inpatient progress. Owing to a 64% increase in estimated cost of investigations with AMS, the total hospital admission cost was increased by approximately 5%. Under the conditions of this study, AMS added to the cost of hospitalization without associated evidence of benefit to the patient.

Australia↗
PubMed1992

Multiphasic screening: an idea whose time has passed.

The theory of screening for preclinical disease requires that early diagnosis and treatment will lead to an outcome which is more favorable than that resulting when treatment is initiated after symptoms appear. In practice, this requirement is met for a surprisingly small number of diseases. Early detection components of "health packages" must be developed, therefore, strictly on the basis of proven effectiveness. Existing programs should be revised in accordance with international guidelines, and adapted as needed to the local incidence and prevalence of disease and anticipated population compliance, so that the maximum benefit of early detection can be realized and the numerous hazards of screening avoided.

Humans↗